SciVision Biotech Inc.
SciVision Biotech Inc., headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in innovative solutions for the healthcare sector. Founded in 2005, the company has made significant strides in developing advanced diagnostic tools and therapeutic products, positioning itself as a trusted name in the field. With a focus on molecular diagnostics and biopharmaceuticals, SciVision Biotech offers unique products that leverage cutting-edge technology to enhance patient care. Their commitment to quality and innovation has earned them recognition in both domestic and international markets, solidifying their reputation as a pioneer in biotechnology. As they continue to expand their operational reach, SciVision Biotech remains dedicated to advancing healthcare through scientific excellence and innovative solutions.
DitchCarbon Score
How does SciVision Biotech Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SciVision Biotech Inc.'s score of 19 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SciVision Biotech Inc.'s reported carbon emissions
In 2023, SciVision Biotech Inc., headquartered in Taiwan (TW), reported total carbon emissions of approximately 130,899.3 kg CO2e, comprising 23,212.5 kg CO2e from Scope 1 and 107,686.8 kg CO2e from Scope 2. This represents a slight increase in emissions compared to 2022, where the total was about 106,378.2 kg CO2e, with 21,952.9 kg CO2e from Scope 1 and 68,425.3 kg CO2e from Scope 2. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments. However, it continues to monitor its greenhouse gas emissions, with a reported emission intensity of about 0.0000122 kg CO2e per USD of revenue in 2023. This indicates a focus on understanding and potentially improving its environmental impact, although no formal climate pledges or science-based targets have been established.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 21,952.9 | 00,000.0 |
| Scope 2 | 68,425.3 | 000,000.0 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SciVision Biotech Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
